Evaluation of Serum Cotinine Cut-Off to Distinguish Smokers From Nonsmokers in the Korean Population
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Cotinine has been widely used as an objective marker to identify current smokers. We conducted this study to address the absence of Korean studies investigating the efficacy of immunoassays and liquid chromatography–tandem mass spectrometry (LC-MS/MS) for the detection of serum cotinine and to determine the optimal serum cotinine cut-off level for differentiating current smokers from nonsmokers. Methods: Serum specimens were obtained from 120 subjects. They were randomly chosen to represent a broad distribution of urine cotinine levels based on a retrospective review of questionnaires and results of urine cotinine levels. We determined serum cotinine levels using the IMMULITE 2000 XPi Immunoassay System (Siemens Healthcare Diagnostics Inc., USA) and LC-MS/MS (API-4000, Applied Biosystems, USA). Correlation was analyzed between IMMULITE serum cotinine, urine cotinine, and LC-MS/MS serum cotinine levels. ROC curve was analyzed to identify the optimal IMMULITE serum cotinine cut-off level for differentiating current smokers from nonsmokers. Results: IMMULITE serum cotinine levels correlated with both urine cotinine and LC-MS/MS serum cotinine levels, with correlation coefficients of 0.958 and 0.986, respectively. The optimal serum cotinine cut-off level for distinguishing current smokers from nonsmokers was 13.2 ng/mL (95.7% sensitivity, 94.1% specificity) using IMMULITE. Conclusions: This is the first study to investigate the use of LC-MS/MS for the measurement of serum cotinine and to determine the optimal serum cotinine cut-off level for the IMMULITE immunoassay. Our results could provide guidelines for differentiating current smokers from nonsmokers in the Korean population.
Abstract
Background: Cotinine has been widely used as an objective marker to identify current smokers. We conducted this study to address the absence of Korean studies investigating the efficacy of immunoassays and liquid chromatography–tandem mass spectrometry (LC-MS/MS) for the detection of serum cotinine and to determine the optimal serum cotinine cut-off level for differentiating current smokers from nonsmokers. Methods: Serum specimens were obtained from 120 subjects. They were randomly chosen to represent a broad distribution of urine cotinine levels based on a retrospective review of questionnaires and results of urine cotinine levels. We determined serum cotinine levels using the IMMULITE 2000 XPi Immunoassay System (Siemens Healthcare Diagnostics Inc., USA) and LC-MS/MS (API-4000, Applied Biosystems, USA). Correlation was analyzed between IMMULITE serum cotinine, urine cotinine, and LC-MS/MS serum cotinine levels. ROC curve was analyzed to identify the optimal IMMULITE serum cotinine cut-off level for differentiating current smokers from nonsmokers. Results: IMMULITE serum cotinine levels correlated with both urine cotinine and LC-MS/MS serum cotinine levels, with correlation coefficients of 0.958 and 0.986, respectively. The optimal serum cotinine cut-off level for distinguishing current smokers from nonsmokers was 13.2 ng/mL (95.7% sensitivity, 94.1% specificity) using IMMULITE. Conclusions: This is the first study to investigate the use of LC-MS/MS for the measurement of serum cotinine and to determine the optimal serum cotinine cut-off level for the IMMULITE immunoassay. Our results could provide guidelines for differentiating current smokers from nonsmokers in the Korean population.
참고문헌 (35)
- Fielding JE, "Health effects of involuntary smoking", N Engl J Med, 319, pp.1452~1460 (1988)
- Stead LF, "Physician advice for smoking cessation", Cochrane Database Syst Rev, pp.CD000165~ (2008)
- Jemal A, "Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control", J Natl Cancer Inst, 100, pp.1672~1694 (2008)
- Jarvis MJ, "Comparison of tests used to distinguish smokers from nonsmokers", Am J Public Health, 77, pp.1435~1438 (1987)
- Binnie V, "The validation of self-reported smoking status by analysing cotinine levels in stimulated and unstimulated saliva, serum and urine", Oral Dis, 10, pp.287~293 (2004)
- Zevin S, "Cotinine effects on nicotine metabolism", Clin Pharmacol Ther, 61, pp.649~654 (1997)
- Bramer SL, "Clinical considerations in study designs that use cotinine as a biomarker", Biomarkers, 8, pp.187~203 (2003)
- Florescu A, "Reference values for hair cotinine as a biomarker of active and passive smoking in women of reproductive age, pregnant women, children, and neonates: systematic review and meta-analysis", Ther Drug Monit, 29, pp.437~446 (2007)
- Kuo HW, "Determination of urinary and salivary cotinine using gas and liquid chromatography and enzyme-linked immunosorbent assay", J Chromatogr B Analyt Technol Biomed Life Sci, 768, pp.297~303 (2002)
- Pacifici R, "Environmental tobacco smoke: nicotine and cotinine concentration in semen", Environ Res, 68, pp.69~72 (1995)
- Tzatzarakis MN, "Hair nicotine", cotinine concentrations as a method of monitoring exposure to tobacco smoke among infants and adults, 2012, pp.31, 258~265
- Agaku IT, "Validation of self-reported smokeless tobacco use by measurement of serum cotinine concentration among US adults", Am J Epidemiol, 180, pp.749~754 (2014)
- Alshaarawy O, "Association of serum cotinine levels and hypertension in never smokers", Hypertension, 61, pp.304~308 (2013)
- Benowitz NL, "Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial", ethnic groups in the United States between 1999 and 2004, 2009, pp.169, 236~248
- Signorello LB, "Racial differences in serum cotinine levels of smokers", Dis Markers, 27, pp.187~192 (2009)
- 정성모, "Urine Cotinine for Assessing Tobacco Smoke Exposure in Korean: Analysis of the Korea National Health and Nutrition Examination Survey (KNHANES)", Tuberculosis and Respiratory Diseases, 73(4), pp.210~218 (2012), 대한결핵및호흡기학회[DOI]
- Haufroid V, "Urinary cotinine as a tobacco-smoke exposure index: a minireview", Int Arch Occup Environ Health, 71, pp.162~168 (1998)
- 김정유, "보건소 금연클리닉의 금연치료 결과에 대한 자가보고와 요중 코티닌 검사 간의 일치도", 대한정신약물학회지, 21(4), pp.210~215 (2010), 대한정신약물학회
- 이소룡, "부산, 울산 및 경남지역의 간접흡연 노출에 의한 직업군별 요중 코티닌 농도", Annals of Occupational and Environmental Medicine, 23(1), pp.42~52 (2011), 대한직업환경의학회
- 전형준, "Self-reported Smoking and Urinary Cotinine Levels among Pregnant Women in Korea and Factors Associated with Smoking during Pregnancy", Journal of Korean Medical Science, 25(5), pp.752~757 (2010), 대한의학회
- 강윤희, "흡연자 선별을 위한 요중 코티닌 검사의 유용성", Annals of Laboratory Medicine, 23(2), pp.92~97 (2003), 대한진단검사의학회
- Caraballo RS, "Self-reported cigarette smoking vs. serum cotinine among U.S. adolescents", Nicotine Tob Res, 6, pp.19~25 (2004)
- Caraballo RS, "Factors associated with discrepancies between self-reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older: Third National Health and Nutrition Examination Survey, 1988-1994", Am J Epidemiol, 153, pp.807~814 (2001)
- Benowitz NL, "Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers", Clin Pharmacol Ther, 53, pp.316~323 (1993)
- Jarvis MJ, "Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure", Am J Public Health, 78, pp.696~698 (1988)
- Caraballo RS, "Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991", JAMA, 280, pp.135~139 (1998)
- Wagenknecht LE, "Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study", Am J Public Health, 80, pp.1053~1056 (1990)
- Pirkle JL, "Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke: 1988-2002", Environ Health Perspect, 114, pp.853~858 (2006)
- Pirkle JL, "Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991", JAMA, 275, pp.1233~1240 (1996)
- Wei B, "Urinary concentrations of PAH and VOC metabolites in marijuana users", Environ Int, 88, pp.1~8 (2015)
- Wei B, "Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012", J Expo Sci Environ Epidemiol, 26, pp.249~256 (2016)
- Murphy SE, "Characterization of multiple products of cytochrome P450 2A6-catalyzed cotinine metabolism", Chem Res Toxicol, 12, pp.639~645 (1999)
- Yamazaki H, "Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes", Arch Toxicol, 73, pp.65~70 (1999)
- Yang M, "Individual differences in urinary cotinine levels in Japanese smokers: relation to genetic polymorphism of drug-metabolizing enzymes", Cancer Epidemiol Biomarkers Prev, 10, pp.589~593 (2001)
- Kwon JT, "Nicotine metabolism and CYP2A6 allele frequencies in Koreans", Pharmacogenetics, 11, pp.317~323 (2001)